| Literature DB >> 28947637 |
Ruth Dobson1, Hannah R Cock1,2, Peter Brex3, Gavin Giovannoni4,5.
Abstract
Vitamin D testing and supplementation is of great interest to neurologists and their patients. Recommended nutritional intakes of vitamin D in the UK remain focused on bone health, despite increasing evidence for a role outside this area. Here we discuss how neurologists might approach vitamin D testing and supplementation, focusing on two conditions associated with vitamin D deficiency that have an increased risk of downstream complications resulting from these: multiple sclerosis and epilepsy. We set out a rationale for testing serum 25-hydroxyvitamin D concentrations and discuss our personal practice in terms of supplementation, with evidence where available. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: epilepsy; multiple sclerosis; osteoporosis; supplementation; vitamin D
Mesh:
Substances:
Year: 2017 PMID: 28947637 DOI: 10.1136/practneurol-2017-001720
Source DB: PubMed Journal: Pract Neurol ISSN: 1474-7758